Anderson Fisher »

Ultragenyx Pharmaceutical shares owned by Anderson Fisher

Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by Anderson Fisher from 13F filings

Historical chart of Anderson Fisher investment in Ultragenyx Pharmaceutical

23:59:59.999Dec 30, 202423:59:59.999500:00:00Dec 31, 202400:00:00.000500:00:00.00142.069k42.0695k42.07k42.0705k42.071k999999.510001,000.51001
Value ($)Share countHistorical RARE position of Anderson Fisher Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Ultragenyx Pharmaceutical held by Anderson Fisher consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ultragenyx Pharmaceutical by Anderson Fisher

Quarter filed Position value Share count Share price at filing
2024-12-31 $42k 1.0k 42.07

More positions owned by Anderson Fisher

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Specialized Funds Div App Etf (VIG)
Vanguard Whitehall Fds High Div Yld (VYM)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Bd Index Fds Intermed Term (BIV)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard World Esg Us Stk Etf (ESGV)
Vanguard Whitehall Fds Intl High Etf (VYMI)
Vanguard Whitehall Fds Intl Dvd Etf (VIGI)

View all positions for Anderson Fisher

Top funds holding Ultragenyx Pharmaceutical

Vanguard Group
BlackRock
Sands Capital Management
State Street Corporation
T. Rowe Price Associates
Wellington Management Company
ClearBridge Advisors
Federated Investors
Rtw Investments
Rock Springs Capital Management
Invesco
Deutsche Bank Aktiengesellschaft
Alkeon Capital Management
Alliancebernstein
Baker Bros. Advisors

View all funds holding Ultragenyx Pharmaceutical